pramipexole dihydrochloride 0.125 MG Oral Tablet
1 INDICATIONS & USAGE Pramipexole dihydrochloride tablets are a non-ergot dopamine agonist indicated for the treatment of: · Parkinson’s disease (PD) ( 1.1 ) • Moderate-to-severe primary Restless Legs Syndrome (RLS) ( 1.2 ) 1.1 Parkinson's Disease Pramipexole dihydrochloride tablets are indicated for the treatment Parkinson's disease. 1.2 Restless Legs Syndrome Pramipexole dihydrochloride tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
Macleods Pharmaceuticals Limited
ROUND WHITE CL 2
CL 2 ROUND WHITE
Related Pills
Pramipexole dihydrochloride Pramipexole dihydrochloride 0.25 MG Oral Tablet
Macleods Pharmaceuticals Limited
Guaifenesin 400 MG Oral Tablet
Sunrise Pharmaceutical Inc
Chlorpheniramine Maleate 4 MG Oral Tablet
Unifirst First Aid Corporation
guiafenesin tablet
sunrise pharmaceutical inc
pain relief extra strength acetaminophen tablet
good sense (geiss, destin & dunn, inc.)
guiafenesin tablet
sunrise pharmaceutical inc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied Pramipexole dihydrochloride tablets are available as follows: 0.125 mg: white coloured, circular, flat, beveled edged uncoated tablet debossed 'CL' on one side of the tablet and '2' on the other side. Bottles of 90's NDC 33342-031-10 Bottles of 500's NDC 33342-031-15 Unit dose blister Pack of 30's NDC 33342-031-06 Unit dose blister pack of 100's NDC 33342-031-12 0.25 mg: white coloured, oval shaped, uncoated tablet with 'CL' and '3' debossed on one side of the tablet with breakline separating 'CL' and '3' and having a breakline on the other side. Bottles of 90's NDC 33342-032-10 Bottles of 500's NDC 33342-032-15 Unit dose blister pack of 30's NDC 33342-032-06 Unit dose blister pack of 100's NDC 33342-032-12 0.5 mg: white coloured, oval shaped, uncoated tablet with 'CL' and '4' debossed on one side of the tablet with breakline separating 'CL' and '4' and having a breakline on the other side. Bottles of 90's NDC 33342-033-10 Bottles of 500's NDC 33342-033-15 Unit dose blister pack of 30's NDC 33342-033-06 Unit dose blister pack 100's NDC 33342-033-12 1 mg: white coloured, flat, circular, beveled edged uncoated tablet with 'CL' and '5' debossed on one side of the tablet with breakline separating 'CL' and '5' and having a breakline on the other side. Bottles of 90's NDC 33342-034-10 Bottles of 500's NDC 33342-034-15 Unit dose blister pack of 30's NDC 33342-034-06 Unit dose blister pack of 100s NDC 33342-034-12 1.5 mg: white coloured, flat, circular, beveled edged uncoated tablet with 'CL' and '6' debossed on one side of the tablet with breakline separating 'CL' and '6' and having a breakline on the other side. Bottles of 90's NDC 33342-035-10 Bottles of 500's NDC 33342-035-15 Unit dose blister pack of 30's NDC 33342-035-06 Unit dose blister pack of 100's NDC 33342-035-12 16.2 Storage and Handling Store pramipexole dihydrochloride tablet at 20° to 25°C (68° to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from light. Store in a safe place out of the reach of children.
More pills like ROUND CL 2